{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:39:47Z","timestamp":1791405587101,"version":"4.3.3"},"reference-count":93,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0127266","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T18:07:16Z","timestamp":1431626836000},"page":"e0127266","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["High Incidence of ACE\/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin"],"prefix":"10.1371","volume":"10","author":[{"given":"Jeanne d\u2019Arc","family":"AlBacha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charbel","family":"Mouawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Hamoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Fajloun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehman","family":"Makdissy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart disease and stroke statistics update: a report from the American Heart Association","volume":"123","author":"VL Roger","year":"2011","journal-title":"Circulation"},{"issue":"7347","key":"ref2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"P Libby","year":"2011","journal-title":"Nature"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","article-title":"Insulin resistance, hyperglycemia, and atherosclerosis","volume":"14","author":"KE Bornfeldt","year":"2011","journal-title":"Cell Metab"},{"issue":"21","key":"ref4","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1161\/01.CIR.0000128519.60762.84","article-title":"Atherosclerotic Vascular Disease Conference: Writing Group II: risk factors","volume":"109","author":"SC Smith Jr.","year":"2004","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.1992.03480010078028","article-title":"Plasma cholesterol concentration and mortality: the Whitehall Study","volume":"267","author":"GD Smith","year":"1992","journal-title":"JAMA"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCULATIONAHA.112.000500","article-title":"Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988\u20132010","volume":"128","author":"BM Egan","year":"2013","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0092-8674(92)90275-H","article-title":"Molecular basis of human hypertension: role of angiotensinogen","volume":"71","author":"X Jeunemaitre","year":"1992","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/01.HYP.0000072269.19820.0D","article-title":"Heritability of blood pressure and hemodynamics in African-and European-American youth","volume":"41","author":"H Snieder","year":"2003","journal-title":"Hypertension"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1093\/hmg\/ddh078","article-title":"Genetics of essential hypertension","volume":"13","author":"CA Mein","year":"2004","journal-title":"Hum Mol Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.amjmed.2003.12.032","article-title":"Genetic Epidemiology Network of Arteriopathy study. Familial aggregation of hypertension treatment and control in the Genetic Epidemiology Network of Arteriopathy (GENOA) study","volume":"116","author":"PR Daniels","year":"2004","journal-title":"Am J Med"},{"issue":"1\u20133","key":"ref11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0167-0115(00)00178-6","article-title":"The multiple actions of angiotensin II in atherosclerosis","volume":"93","author":"KM Schmidt-Ott","year":"2000","journal-title":"Regul Pept"},{"issue":"8A","key":"ref12","doi-asserted-by":"crossref","first-page":"25C","DOI":"10.1016\/S0002-9149(01)01539-9","article-title":"Angiotensin II and atherosclerosis","volume":"87","author":"D Weiss","year":"2001","journal-title":"Am J Cardiol"},{"issue":"22","key":"ref13","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/01.CIR.97.22.2202","article-title":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor myocardial infarction collaborative group","volume":"97","year":"1998","journal-title":"Circulation"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/01.CIR.94.4.708","article-title":"A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction","volume":"94","author":"NJ Samani","year":"1996","journal-title":"Circulation"},{"issue":"9202","key":"ref15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(00)82009-7","article-title":"Large-scale test of hypothesized associations between the angiotensin- converting-enzyme insertion\/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International studies of infarct survival (ISIS) collaborators","volume":"355","author":"B Keavney","year":"2000","journal-title":"Lancet"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/heart.89.10.1195","article-title":"Epistatic interaction between variations in the angiotensin I converting enzyme and angiotensin II type 1 receptor genes in relation to extent of coronary atherosclerosis","volume":"89","author":"S Ye","year":"2003","journal-title":"Heart"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/gte.2007.0005","article-title":"Modification of the coronary artery disease risk associated with the presence of traditional risk factors by insertion\/deletion polymorphism of the ACE gene","volume":"11","author":"P Niemiec","year":"2007","journal-title":"Genet Test"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.gene.2012.02.033","article-title":"Renin-angiotensin system genes polymorphism in Egyptians with premature coronary artery disease","volume":"498","author":"TA Abd El-Aziz","year":"2012","journal-title":"Gene"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/01.CIR.92.3.657","article-title":"Coronary plaque disruption","volume":"92","author":"E Falk","year":"1995","journal-title":"Circulation"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0033-1334487","article-title":"Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin","volume":"39","author":"PJ Declerck","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1160\/TH06-12-0745","article-title":"Association between the plasminogen activator inhibitor-1 4G\/5G polymorphism and venous thrombosis. A meta-analysis","volume":"97","author":"AE Tsantes","year":"2007","journal-title":"Thromb Haemost"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00001721-199609000-00001","article-title":"Venous thrombosis revisited","volume":"7","author":"DP Thomas","year":"1996","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6475","key":"ref23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"RM Bertina","year":"1994","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.1997.03540400055031","article-title":"Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening","volume":"277","author":"PM Ridker","year":"1997","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(95)91803-5","article-title":"World distribution of factor V Leiden","volume":"346","author":"DC Rees","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/1096-8652(200009)65:1<45::AID-AJH8>3.0.CO;2-V","article-title":"The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese","volume":"65","author":"N Irani-Hakime","year":"2000","journal-title":"Am J Hematol"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11033-006-9013-y","article-title":"Angiotensin-converting enzyme gene polymorphism and allele frequencies in the Lebanese population: prevalence and review of the literature","volume":"34","author":"AS Sabbagh","year":"2007","journal-title":"Mol Biol Rep"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11033-007-9106-2","article-title":"Plasminogen Activator Inhibitor-1 (PAI-1) gene 4G\/5G alleles frequency distribution in the Lebanese population","volume":"35","author":"DM Shammaa","year":"2008","journal-title":"Mol Biol Rep"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1183\/09031936.00050106","article-title":"Genotype-corrected reference values for serum angiotensin-converting enzyme","volume":"28","author":"H Biller","year":"2006","journal-title":"Eur Respir J"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11033-007-9087-1","article-title":"Frequency distribution of the G\/A alleles of the beta-fibrinogen gene in the Lebanese population","volume":"35","author":"DM Shammaa","year":"2008","journal-title":"Mol Biol Rep"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-3148.2007.00792.x","article-title":"Gene frequencies of the HPA-1 platelet antigen alleles in the Lebanese population","volume":"17","author":"AS Sabbagh","year":"2007","journal-title":"Transfus Med"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11033-006-6260-x","article-title":"Apolipoprotein E gene polymorphism and allele frequencies in the Lebanese population","volume":"33","author":"RA Mahfouz","year":"2006","journal-title":"Mol Biol Rep"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S0029665107005435","article-title":"ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation","volume":"66","author":"AM Minihane","year":"2007","journal-title":"Proc Nutr Soc"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.5152\/akd.2010.058","article-title":"Relationship between severity of coronary artery disease and apolipoprotein E gene polymorphism","volume":"10","author":"Ince FD Arslan","year":"2010","journal-title":"Anadolu Kardiyol Derg"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11033-006-9041-7","article-title":"ApoB-100 R3500Q mutation in the Lebanese population: prevalence and historical review of the literature","volume":"34","author":"AS Sabbagh","year":"2007","journal-title":"Mol Biol Rep"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-1809.2011.00682.x","article-title":"mtDNA lineages reveal coronary artery disease-associated structures in the Lebanese population","volume":"76","author":"M Haber","year":"2012","journal-title":"Ann Hum Genet"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/gte.2007.0064","article-title":"High prevalence of MTHFR gene A1298C polymorphism in Lebanon","volume":"12","author":"AS Sabbagh","year":"2008","journal-title":"Genet Test"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-007-9434-5","article-title":"MTHFR 677 CT\/MTHFR 1298 CC genotypes are associated with increased risk of hypertension in Indians","volume":"302","author":"S Markan","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"ref39","first-page":"287","article-title":"The MTHFR 677TT and 677CT\/1298AC genotypes in Cypriot patients may be predisposing to hypertensive nephrosclerosis and chronic renal failure","volume":"24","author":"P Koupepidou","year":"2005","journal-title":"Int Angiol"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1024\/0300-9831.78.1.33","article-title":"Low plasma pyridoxal 5\u2032-phosphate concentration and MTHFR 677C\u2014&gt;T genotypes are associated with increased risk of hypertension","volume":"78","author":"PT Lin","year":"2008","journal-title":"Int J Vitam Nutr Res"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.12816\/0005968","article-title":"Association of MTHFR C677T and A1298C gene polymorphisms with hypertension","volume":"6","author":"A Alghasham","year":"2012","journal-title":"Int J Health Sci (Qassim)"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"e87497","DOI":"10.1371\/journal.pone.0087497","article-title":"Associations of MTHFR Gene Polymorphisms with Hypertension and Hypertension in Pregnancy: A Meta-Analysis from 114 Studies with 15411 Cases and 21970 Controls","volume":"9","author":"B Yang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.arcmed.2007.07.009","article-title":"The 677 C\/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels","volume":"39","author":"N Ilhan","year":"2008","journal-title":"Arch Med Res"},{"issue":"8","key":"ref44","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0002-9149(00)01103-6","article-title":"Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia","volume":"86","author":"M Kawashiri","year":"2000","journal-title":"Am J Cardiol"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11033-007-9096-0","article-title":"Factor XIII gene V34L mutation in the Lebanese population: another unique feature in this community?","volume":"35","author":"RA Mahfouz","year":"2008","journal-title":"Mol Biol Rep"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/00313020600922934","article-title":"Prevalence of factor V R2 (H1299R) polymorphism in the Lebanese population","volume":"38","author":"GS Zaatari","year":"2006","journal-title":"Pathology"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000093108","article-title":"Influence of factor V HR2 on thrombin generation and clinical manifestation in rare bleeding disorders","volume":"34","author":"RF Strey","year":"2005","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"3","key":"ref48","first-page":"257","article-title":"Utility of testing for factor V Leiden","volume":"10","author":"M Franchini","year":"2012","journal-title":"Blood Transfus"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1011268531377","article-title":"Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease","volume":"11","author":"N Irani-Hakime","year":"2001","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0897.2006.00419.x","article-title":"Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss?","volume":"56","author":"CS Goodman","year":"2006","journal-title":"Am J Reprod Immunol"},{"issue":"11","key":"ref51","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/sj.jhh.1001909","article-title":"The prevalence of hypertensionand its association with other cardiovascular disease risk factors in a representative sample of the Lebanese population","volume":"19","author":"RA Tohme","year":"2005","journal-title":"J Hum Hypertens"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/1470320311408465","article-title":"The association of hypertension with renin-angiotensin system gene polymorphisms in the Lebanese population","volume":"12","author":"YB Saab","year":"2011","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"6","key":"ref53","first-page":"697","article-title":"Epidemiological study of hyperlipemia in a Lebanese population","volume":"57","author":"H Aydenian","year":"1999","journal-title":"Ann Biol Clin (Paris)"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ymgme.2010.11.006","article-title":"Homozygous familial hypercholesterolemia in Lebanon: a genotype\/phenotype correlation","volume":"102","author":"AC Fahed","year":"2011","journal-title":"Mol Genet Metab"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/01.HYP.0000068681.69874.CB","article-title":"Associations between hypertension and genes in the renin-angiotensin system","volume":"41","author":"X Zhu","year":"2003","journal-title":"Hypertension"},{"key":"ref56","first-page":"31","article-title":"Angiotensin converting enzyme gene I\/d polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean people","volume":"10","author":"J Barley","year":"1996","journal-title":"J Hum Hypertens"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2337\/diacare.24.2.356","article-title":"Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of the ace insertion\/deletion polymorphism with type 2 diabetes","volume":"24","author":"GN Thomas","year":"2001","journal-title":"Diabetes Care"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1291\/hypres.25.481","article-title":"Angiotensin-converting enzyme gene polymorphism and its association with essential hypertension in a Tibetan population","volume":"25","author":"L Gesang","year":"2002","journal-title":"Hypertens Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.jhh.1001601","article-title":"Relation between the angiotensin-converting enzyme insertion\/deletion polymorphism and blood pressure in Japanese male subjects","volume":"17","author":"M Todoroki","year":"2003","journal-title":"J Hum Hypertens"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1353\/hub.2004.0012","article-title":"Angiotensin-converting enzyme gene (ACE) insertion\/deletion polymorphism in Mexican populations","volume":"75","author":"G Vargas-Alarcon","year":"2003","journal-title":"Hum Biol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/emm.2003.71","article-title":"Angiotensin converting enzyme I\/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients","volume":"35","author":"B Agachan","year":"2003","journal-title":"Exp Mol Med"},{"key":"ref62","first-page":"552","article-title":"Association between the angiotensin-converting enzyme gene insertion\/deletion polymorphism and essential hypertension in young Pakistani patients","volume":"37","author":"M Ismail","year":"2004","journal-title":"J Biochem Mol Biol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejheart.2003.07.009","article-title":"Does angiontensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow up in healthy subjects","volume":"6","author":"P Di Pasquale","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2369-7-15","article-title":"Prevalence of ACE DD genotype among North Indian end stage renal disease patients","volume":"7","author":"G Tripathi","year":"2006","journal-title":"BMC Nephrol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.jhh.1002110","article-title":"Interaction between GNB3 C825T and ACE I\/D polymorphisms in essential hypertension in Koreans","volume":"21","author":"Y Bae","year":"2007","journal-title":"J Hum Hypertens"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1476-511X-12-177","article-title":"Association of angiotensin converting enzyme gene insertion\/deletion polymorphism and familial hypercholesterolemia in the Saudi population","volume":"12","author":"KK Alharbi","year":"2013","journal-title":"Lipids Health Dis"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/01.CIR.97.18.1780","article-title":"Angiotensin-converting enzyme DD genotype and cardiovascular risk in heterozygous familial hypercholesterolemia","volume":"97","author":"JP O\u2019Malley","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"ref68","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0735-1097(96)00098-8","article-title":"The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure","volume":"28","author":"B Andersson","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"ref69","first-page":"8","article-title":"Role of Genetic Polymorphism of Angiotensin-Converting Enzyme, Plasminogen Activator Inhibitor-1 and Endothelial Nitric Oxide Synthase in the Prognosis of Coronary Artery Disease","volume":"1","author":"AY Zhang","year":"2010","journal-title":"Cardiol Res"},{"issue":"11","key":"ref70","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1161\/01.ATV.17.11.3242","article-title":"Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1","volume":"17","author":"DK Kim","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)82047-6","article-title":"The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells","volume":"268","author":"SJ Dawson","year":"1993","journal-title":"J Biol Chem"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","article-title":"Allelic-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction","volume":"92","author":"P Eriksson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref73","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/01.ATV.18.2.152","article-title":"The PAI-1 gene locus 4G\/5G polymorphism is associated with a family history of coronary artery disease","volume":"18","author":"M Margaglione","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"ref74","first-page":"1681","article-title":"Association of angiotensin I-converting enzyme gene polymorphism with ACE and PAI-1 levels in Guangdong Chinese Han patients with essential hypertension","volume":"27","author":"YL Zhang","year":"2007","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"2\u20133","key":"ref75","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000093604","article-title":"An effect of the PAI-1 4G\/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke","volume":"22","author":"GB Boncoraglio","year":"2006","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"ref76","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.RES.73.4.671","article-title":"Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type 1 by endothelial injury","volume":"73","author":"H Sawa","year":"1993","journal-title":"Circ Res"},{"issue":"3","key":"ref77","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/ATVBAHA.107.155556","article-title":"Plasminogen activator inhibitor-1 polymorphism (4G\/5G) predicts recurrence in nonhyperlipidemic postinfarction patients","volume":"28","author":"JP Corsetti","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"ref78","first-page":"449","article-title":"Genotype combinations of plasminigen activator inhibitor-1 and angiotensin converting enzyme genes and risk for early onset of coronary heart disease","volume":"13","author":"M Loew","year":"2006","journal-title":"Eur J CardivascPrevRehabil"},{"issue":"11","key":"ref79","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.5858\/2002-126-1391-FXPAVT","article-title":"Factor XIII polymorphisms and venous thromboembolism","volume":"126","author":"CW Francis","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0037-1614250","article-title":"Association of a common polymorphism in the factor XIII gene with myocardial infarction","volume":"79","author":"HP Kohler","year":"1998","journal-title":"Thromb Haemost"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood.V96.3.988","article-title":"The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure","volume":"96","author":"RA Ariens","year":"2000","journal-title":"Blood"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1161\/01.ATV.17.10.2082","article-title":"Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes","volume":"17","author":"M Margaglione","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Chen F, Qiao Q, Xu P, Fan B, Chen Z. Effect of Factor XIII-A Val34Leu Polymorphism on Myocardial Infarction Risk: A Meta-Analysis. Clin Appl Thromb Hemost 2013 Sep 15.","DOI":"10.1177\/1076029613504130"},{"issue":"2","key":"ref84","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1160\/TH09-01-0013","article-title":"The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls","volume":"102","author":"R Gohil","year":"2009","journal-title":"Thromb Haemost"},{"issue":"23","key":"ref85","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/eurheartj\/ehp477","article-title":"Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies","volume":"30","author":"R Klingenberg","year":"2009","journal-title":"European Heart Journal"},{"issue":"16","key":"ref86","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/01.CIR.0000089190.95415.9F","article-title":"New markers of inflammation and endothelial cell activation: part I","volume":"108","author":"PE Szmitko","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"ref87","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.110.207415","article-title":"Recent advances on the role of cytokines in atherosclerosis","volume":"31","author":"H Ait-Oufella","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.biopha.2010.12.005","article-title":"The effect of atorvastatin on mRNA levels of inflammatory genes expression in human peripheral blood lymphocytes by DNA microarray","volume":"65","author":"Y Wang","year":"2011","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"ref89","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2174\/138161212799504803","article-title":"Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials","volume":"18","author":"AS Antonopoulos","year":"2012","journal-title":"Current Pharmaceutical Design"},{"issue":"4","key":"ref90","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/03009740802572475","article-title":"Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis","volume":"38","author":"S Blaschke","year":"2009","journal-title":"Scand J Rheumatol"},{"issue":"3\u20134","key":"ref91","first-page":"41","article-title":"The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells","volume":"131","author":"B Kwak","year":"2001","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"ref92","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2004.07.003","article-title":"Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients","volume":"177","author":"E Ascer","year":"2004","journal-title":"Atherosclerosis"},{"issue":"4","key":"ref93","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.4238\/2013.December.19.8","article-title":"Effects of ACE polymorphisms and other risk factors on the severity of coronary artery disease","volume":"12","author":"AI Guney","year":"2013","journal-title":"Genet Mol Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0127266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T04:02:24Z","timestamp":1651982544000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0127266"}},"subtitle":[],"editor":[{"given":"Karin","family":"Jandeleit-Dahm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":93,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0127266","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,14]]}}}